Israel Gutierrez
About Israel Gutierrez
Israel Gutierrez serves as the Vice President of Drug Safety and Pharmacovigilance at Geron Corporation, bringing over 20 years of experience in the pharmaceutical industry. He has held various leadership roles at companies such as Exelixis, Celgene, and Genentech, and possesses extensive knowledge in drug safety and regulatory guidelines.
Current Role at Geron Corporation
Israel Gutierrez serves as the Vice President of Drug Safety and Pharmacovigilance at Geron Corporation. He has held this position since 2019, contributing to the company's focus on drug safety and regulatory compliance. His role involves overseeing pharmacovigilance activities, ensuring that the safety of pharmaceutical products is maintained throughout their lifecycle.
Previous Experience at Exelixis
Prior to his current role, Israel Gutierrez worked at Exelixis as the Vice President of Drug Safety from 2013 to 2015. During his tenure in South San Francisco, he was responsible for managing drug safety operations and contributed to the development of safety protocols within the organization.
Experience at Celgene
Israel Gutierrez served as the Senior Director of Global Safety Scientist and Medical Affairs Director at Celgene from 2004 to 2010. His six years at the company involved overseeing global safety initiatives and ensuring compliance with safety regulations in the pharmaceutical industry.
Educational Background
Israel Gutierrez has an extensive educational background in medicine and management. He earned his MD from Universidad Autonoma de Guadalajara from 1987 to 1992. He also studied at the University of Southern California, where he achieved a Science Fellow in Medicine from 1995 to 1997, and later completed studies in Management Science at the University of California San Diego from 1999 to 2000. Additionally, he attended the University of Chicago Booth School of Business for Organizational Leadership from 2004 to 2005 and the MIT Sloan School of Management for Artificial Intelligence from 2018 to 2019.
Expertise in Drug Safety and Pharmacovigilance
Israel Gutierrez possesses deep knowledge of ICH Guidelines, GCP, GVPV, and GLP, alongside expertise in biologic processes and pathways. He has over 20 years of experience in building multi-functional pharmaceutical development teams and managing partnerships. His skills include Benefit-Risk Quantification and risk management in drug development, which are critical for ensuring patient safety and regulatory compliance.